Assistant Professor of Medicine
Specialty: Interventional cardiology
Medical School: University of Texas Medical Branch, Galveston, Texas
Residency: Mt. Sinai Medical Center, New York
Fellowship: Molecular Medicine, Mt. Sinai Medical Center, New York; Cardiology, University of California at San Francisco, San Francisco, California; Interventional cardiology, Mayo Clinic, Rochester, Minnesota.
Clinical interests: Cardiac complications associated with renal failure and diabetes.
Research Interests: Investigation in risks of cardiovascular disease in people with diabetes mellitus and renal disease. Investigation in contrast nephropathy
Professional Organizations: American College of Cardiology
Recent Publications:
Caplice NM, Panetta C, Peterson TE, Kleppe LS, Mueske CS, Kostner GM, Broze GJ Jr, Simari RD. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood. 2001 Nov 15; 98(10):2980-7.
Stalboerger PG, Panetta CJ, Simari RD, Caplice NM. Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor. Thromb Haemost. 2001 Sep; 86(3):923-8.
Panetta CJ, Miyauchi K, Berry D, Simari RD, Holmes DR, Schwartz RS, Caplice NM. A tissue-engineered stent for cell-based vascular gene transfer. Hum Gene Ther. 2002 Feb 10; 13(3):433-41.
Simper D, Stalboerger PG, Panetta CJ, Wang S, Caplice NM. Smooth muscle progenitor cells in human blood. Circulation. 2002 Sep 3; 106(10):1199-204.